| Target Price | $198.90 |
| Price | $157.18 |
| Potential |
26.54%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target ICU Medical, Inc. 2027 .
The average ICU Medical, Inc. target price is $198.90.
This is
26.54%
register free of charge
$220.50
40.29%
register free of charge
$188.87
20.16%
register free of charge
|
|
| A rating was issued by 13 analysts: 12 Analysts recommend ICU Medical, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the ICU Medical, Inc. stock has an average upside potential 2027 of
26.54%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.23 | 2.24 |
| 6.33% | 0.17% | |
| EBITDA Margin | 4.99% | 19.39% |
| 14.26% | 288.82% | |
| Net Margin | 0.03% | 9.99% |
| 100.66% | 30,434.64% |
10 Analysts have issued a sales forecast ICU Medical, Inc. 2026 . The average ICU Medical, Inc. sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an ICU Medical, Inc. EBITDA forecast 2026. The average ICU Medical, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 ICU Medical, Inc. Analysts have issued a net profit forecast 2026. The average ICU Medical, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.03 | 8.93 |
| 100.62% | 29,666.67% | |
| P/E | 17.98 | |
| EV/Sales | 2.22 |
10 Analysts have issued a ICU Medical, Inc. forecast for earnings per share. The average ICU Medical, Inc. EPS is
This results in the following potential growth metrics and future valuations:
ICU Medical, Inc....
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BTIG |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| Keybanc |
Locked
➜
Locked
|
Locked | Jul 21 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Jun 15 2026 |
| Needham |
Locked
➜
Locked
|
Locked | May 27 2026 |
| Keybanc |
Locked
➜
Locked
|
Locked | Apr 27 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
BTIG:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Jul 21 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Jun 15 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
May 27 2026 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Apr 27 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


